Trial Profile
Safety and Efficacy of CDB-2914 [ulipristal] in Comparison to Levonorgestrel for Emergency Contraception
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 May 2022
Price :
$35
*
At a glance
- Drugs Ulipristal (Primary) ; Levonorgestrel
- Indications Pregnancy
- Focus Registrational; Therapeutic Use
- Sponsors HRA Pharma
- 29 Jan 2010 Results published in the Lancet.
- 11 Nov 2009 Actual end date (1 Apr 2009) added as reported by ClinicalTrials.gov.
- 11 Nov 2009 Actual patient number (2321) added as reported by ClinicalTrials.gov.